Studies on tissue-specific FXR-deficient mice have shown that intestinal FXR is required for high-fat diet-induced obesity, insulin resistance, and NAFLD [49]. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.